Literature DB >> 19003942

Toxicological studies of wogonin in experimental animals.

Qi Qi1, Jian Peng, Wei Liu, Qidong You, Yong Yang, Na Lu, Guangji Wang, Qinglong Guo.   

Abstract

Wogonin, one active ingredient extract from the radix of Scutellaria baicalensis Georgi, is known to possess a broad spectrum of pharmacological, medicinal and therapeutic properties, especially the anticancer activity studied recently. However, no extensive safety studies have been conducted to date. In this paper, the acute and sub-chronic toxicity of the agent were determined using albino mice and Sprague-Dawley rats as animal models. Histopathological examination and viscera parameter investigation were also carried out after autopsy. The LD(50) of wogonin administered by the intravenous injection was 286.15 mg/kg and the 95% confidence limit was 278.27-295.26 mg/kg. A long period of treatment with a high dose of wogonin (120 mg/kg) could induce heart injury in rats. These results provide a foundation for the further clinical investigation of this promising anticancer agent. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19003942     DOI: 10.1002/ptr.2645

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  11 in total

1.  Wogonin suppresses osteopontin expression in adipocytes by activating PPARα.

Authors:  Ye-min Zhang; Ming-xin Li; Zhao Tang; Chang-hua Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

2.  Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.

Authors:  Jie Ding; Gernot Polier; Rebecca Köhler; Marco Giaisi; Peter H Krammer; Min Li-Weber
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

3.  Wogonin improves functional neuroprotection for acute cerebral ischemia in rats by promoting angiogenesis via TGF-β1.

Authors:  Zhaohong Kong; Qinglin Shen; Jian Jiang; Min Deng; Zhaohui Zhang; Gaohua Wang
Journal:  Ann Transl Med       Date:  2019-11

4.  Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1.

Authors:  G Polier; J Ding; B V Konkimalla; D Eick; N Ribeiro; R Köhler; M Giaisi; T Efferth; L Desaubry; P H Krammer; M Li-Weber
Journal:  Cell Death Dis       Date:  2011-07-21       Impact factor: 8.469

5.  Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-κB signaling after experimental traumatic brain injury.

Authors:  Chien-Cheng Chen; Tai-Ho Hung; Yen-Ho Wang; Chii-Wann Lin; Pei-Yi Wang; Chun-Yen Lee; Szu-Fu Chen
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

6.  High-dose wogonin exacerbates DSS-induced colitis by up-regulating effector T cell function and inhibiting Treg cell.

Authors:  Weiming Xiao; Min Yin; Keyan Wu; Guotao Lu; Bin Deng; Yu Zhang; Li Qian; Xiaoqing Jia; Yanbing Ding; Weijuan Gong
Journal:  J Cell Mol Med       Date:  2016-09-19       Impact factor: 5.310

7.  Safety evaluation of root extract of Pueraria lobata and Scutellaria baicalensis in rats.

Authors:  Jungbin Song; Young-Sik Kim; Donghun Lee; Hocheol Kim
Journal:  BMC Complement Med Ther       Date:  2020-07-17

Review 8.  The Therapeutic Potential of Wogonin Observed in Preclinical Studies.

Authors:  Javad Sharifi-Rad; Jesús Herrera-Bravo; Luis A Salazar; Shabnum Shaheen; Seyed Abdulmajid Ayatollahi; Farzad Kobarfard; Muhammad Imran; Ali Imran; Luísa Custódio; María Dolores López; Mauricio Schoebitz; Miquel Martorell; Manoj Kumar; Hafiz Ansar Rasul Suleria; William C Cho
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-15       Impact factor: 2.629

9.  Protective effect of Sam-Hwang-Sa-Sim-Tang against hepatic steatosis in mice fed a high-cholesterol diet.

Authors:  Tae-Gue Ahn; Joo-Young Lee; Se-Yun Cheon; Hyo-Jin An; Yoon-Bum Kook
Journal:  BMC Complement Altern Med       Date:  2013-12-23       Impact factor: 3.659

Review 10.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.